Ectopic study of calcium phosphate cement seeded with pBMP-2 modified canine bMSCs mediated by a non-viral PEI derivative

Cell Biology International

Volumn 36, Issue 2, 2012, Pages 119-128

  Lü, Kaige ^a   Zeng, Deliang ^a   Zhang, Wenjie ^a   Xia, Lunguo ^a   Xu, Ling ^a   Jiang, Xinquan ^a   Zhang, Fuqiang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow stromal cells; Bone morphogenetic protein 2 (BMP 2); Calcium phosphate cement (CPC); Non viral gene therapy; Polyethylenimine (PEI)

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CEMENT; CEMENT; COLLAGEN TYPE 1; ENHANCED GREEN FLUORESCENT PROTEIN; OSTEOCALCIN; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MORPHOMETRICS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE ENGINEERING; UPREGULATION;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATES; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; DOGS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, NUDE; OSTEOCALCIN; PLASMIDS; POLYETHYLENEIMINE; STROMAL CELLS; TISSUE ENGINEERING; TRANSFECTION;

MUS MUSCULUS;

EID: 84859262690     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100848     Document Type: Article

References (45)

1. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996;7:1947-54.
2. Ahn HH, Lee MS, Cho MH, Shin YN, Lee JH, Kim KS et al. DNA/PEI nano-particles for gene delivery of rat bone marrow stem cells. Colloid Surf Physicochem Eng Aspect 2008;313:116-20.
3. Apelt D, Theiss F, El-Warrak AO, Zlinszky K, Bettschart-Wolfisberger R, Bohner M et al. In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 2004;25:1439-51.
4. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M et al. Nucleofection-based ex vivo non-viral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 2006;12:877-89.
5. Boussif O, Lezoualc'h F, Zanta MA, Mergny M, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301.
6. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996;3:1074-80.
7. Buser DBU, Lang NP, Nyman S. Regeneration and enlargement of jaw bone using guided tissue regeneration. Clin Oral Implants Res 1990;1:22-32.
8. Calafiori AR, Di Marco G, Martino G, Marotta M. Preparation and characterization of calcium phosphate biomaterials. J Mater Sci Mater Med 2007;18:2331-8.
9. Chiapasco MRE, Vogel G. Vertical distraction osteogenesis of edentulous ridges for improvement of oral implant positioning: a clinical report of preliminary results. Int J Oral Maxillofac Implants 2001;16:43-51.
10. Cybernetics M. Image-Pro Plus - application notes. Silver Spring, MD; Media Cybernetics; 2002.
11. Fischer W, Calderón M, Haag R. Hyperbranched polyamines for transfection. Top Curr Chem 2010;296:95-129.
12. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 2008;10:815-23.
13. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury 2005;36(Suppl 3):S20-7.
14. Hamm A, Krott N, Breibach I, Blindt R, Bosserhoff AK. Efficient transfection method for primary cells. Tissue Eng 2002;8:235-45.
15. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 2007;117:380-6.
16. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Ectopic bone formation in collagen sponge self-assembled peptide-amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 2006;27:5089-98.
17. Jere D, Jiang HL, Arote R, Kim YK, Choi YJ, Cho MH et al. Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv 2009;6:827-34.
18. Jiang XQ, Chen JG, Gittens S, Chen CJ, Zhang XL, Zhang ZY. The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits. Chin Med J (Engl) 2005;118:281-8.
19. Jiang XQ, Gittens SA, Chang Q, Zhang X, Chen C, Zhang Z. The use of tissue-engineered bone with human bone morphogenetic protein-4-modified bone-marrow stromal cells in repairing mandibular defects in rabbits. Int J Oral Maxillofac Surg 2006;35:1133-9.
20. Jiang XQ, Zhao J, Wang SY, Sun XJ, Zhang XL, Chen J et al. Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials 2009a;30:4522-32.
21. Jiang XQ, Sun XJ, Lai HC, Zhao J, Wang SY, Zhang ZY. Maxillary sinus floor elevation using a tissue-engineered bone complex with beta-TCP and BMP-2 gene-modified bMSCs in rabbits. Clin Oral Implants Res 2009b;20:1333-40.
22. Kawai M, Bessho K, Kaihara S, Sonobe J, Oda K, Iizuka T et al. Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation. Hum Gene Ther 2003;14:1547-56.
23. Kim SW, Ogawa T, Tabata Y, Nishimura I. Efficacy and cytotoxicity of cationic-agent-mediated non-viral gene transfer into osteoblasts. J Biomed Mater Res A 2004;71:308-15.
24. Lai CM, Lai YK, and Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002;21:895-913.
25. Li JY, Gu X, Zhang WH, Jia S, Zhou Y. GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats. Hepatobiliary Pancreat Dis Int 2009;8:518-23.
26. Li S, Ma Z. Non-viral gene therapy. Curr Gene Ther 2001;1:201-26.
27. Liu C, Shao H, Chen F, Zheng H. Effects of the granularity of raw materials on the hydration and hardening process of calcium phosphate cement. Biomaterials 2003;24:4103-13.
28. Lu JX, Gallur A, Flautre B, Anselme K, Descamps M, Thierry B et al. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 1998;42:357-67.
29. Merdan T, Kunath K, Fischer D, Kopecek J, Kissel T. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res 2002;19:140-6.
30. Niidome T, Huang L. Gene therapy progress and prospects: non-viral vectors. Gene Ther 2002;9:1647-52.
31. Park J, Ries J, Gelse K, Kloss F, von der Mark K, Wiltfang J et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 2003;10:1089-98.
32. Peng L, Liu M, Xue YN, Huang SW, Zhuo RX. Transfection and intracellular trafficking characteristics for poly(amidoamine)s with pendant primary amine in the delivery of plasmid DNA to bone marrow stromal cells. Biomaterials 2009;30:5825-33.
33. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009a;25:1539-60.
34. Porter JR, Henson A, Popat KC. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Biomaterials 2009b;30:780-8.
35. Prockop D. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4.
36. Strauss EJ, Pahk B, Kummer FJ, Egol K. Calcium phosphate cement augmentation of the femoral neck defect created after dynamic hip screw removal. J Orthop Trauma 2007;21:295-300.
37. Sun XJ, Zhang ZY, Wang SY, Gittens SA, Jiang XQ, Chou LL. Maxillary sinus floor elevation using a tissue-engineered bone complex with OsteoBone (TM) and bMSCs in rabbits. Clin Oral Implants Res 2008;19:804-13.
38. Tadic D, Beckmann F, Schwarz K, Epple M. A novel method to produce hydroxyapatite objects with interconnecting porosity that avoids sintering. Biomaterials 2004;25:3335-40.
39. Tay BK, Patel VV, Bradford DS. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am 1999;30:615-23.
40. Turgeman G, Aslan H, Gazit Z, Gazit D. Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 2002;4:390-4.
41. Wagoner Johnson AJ, Herschler BA. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 2011;7:16-30.
42. Yamano S, Dai J, Moursi AM. Comparison of transfection efficiency of non-viral gene transfer reagents. Mol Biotechnol 2010;46:287-300.
43. Zaragosi LE, Billon N, Ailhaud G, Dani C. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 2007;25:790-7.
44. Zhao J, Zhang ZY, Wang SY, Sun XJ, Zhang XL, Chen J et al. Apatitecoated silk fibroin scaffolds to healing mandibular border defects in canines. Bone 2009;45:517-27.
45. Zong C, Xue D, Yuan W, Wang W, Shen D, Tong X et al. Reconstruction of rat calvarial defects with human mesenchymal stem cells and osteoblast-like cells in poly-lactic-co-glycolic acid scaffolds. Eur Cell Mater 2010;20:109-20.